FDA Inspection 1012572 — McLaren Health Care Corporate Institutional Review Board
The FDA completed an inspection of McLaren Health Care Corporate Institutional Review Board on April 21, 2017 in Auburn Hills, MI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 21, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Auburn Hills, MI (United States)
Additional Details
IRB